Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
about
Colorectal cancer: Metastases to a single organClinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumorLaparoscopic-assisted ablation of hepatic tumors: a reviewLocoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy.Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantationPerioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasisHepatic resection for colorectal metastases: the impact of surgical margin status on outcome.Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis.Diagnostic and prognostic value of preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography for colorectal cancer: comparison with conventional computed tomography.Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases.Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapyTwo-stage strategy for patients with extensive bilateral colorectal liver metastases.Pathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapyImaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study.Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastasesColorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?Chemotherapy and other systemic therapies for hepatocellular carcinoma and liver metastases.FDG-PET in colorectal cancer.Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.Colorectal hepatic metastasis: Evolving therapies.Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis.Open versus laparoscopic liver resection for colorectal liver metastases (the Oslo-CoMet Study): study protocol for a randomized controlled trial.In colorectal liver metastases, the presence of extrahepatic disease correlates with the pathology of the primary tumour.Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignanciesRepeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate.The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operatiOutcomes of resection for colorectal cancer hepatic metastases stratified by evolving eras of treatmentThe influence of FDG PET-CT on the detection of extrahepatic disease in patients being considered for resection of colorectal liver metastasisAccuracy of [18F]FDG PET/MRI for the Detection of Liver MetastasesRecent advances in the curative treatment of colorectal liver metastasesCurative strategies for liver metastases from colorectal cancer: a reviewSurgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patientsAssessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario?Outcomes in patients with indeterminate pulmonary nodules undergoing resection for colorectal liver metastases.Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.[Surgery of colorectal lung metastases : Results of a survey in Germany].Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention.Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site.The potential role of gene expression in the management of primary and metastatic colorectal cancer.
P2860
Q26778009-DB525ACF-21CF-433C-A081-3977DAD5475DQ27005824-5A0DBE8F-0771-44B2-AA1A-ED647B507E17Q27021321-AEE0C4E2-3E61-45CF-A689-E20E41FA2D74Q30415022-2B0EDE96-070A-4943-B94C-C58D2B9F7E40Q33378977-4E664537-05E8-4FC3-8617-0DF83513EEB8Q33594891-E7B28AA0-BB75-44EC-819B-908012FD89D0Q33622791-A3562EA9-2C52-4AD1-8131-07008A8CFB85Q33622797-C279FA8D-433E-4A78-B5BB-05F6CD5BFA51Q33656676-2DCDEFE8-3F20-4B0D-B78B-1C9129C5DE7EQ33679151-29DA07FB-53BF-4820-967A-ED305A2E89F8Q33679628-19E71DDA-BAE1-4418-9754-D194025E5B75Q33850248-DF089AFA-E7C0-4961-90E7-CE0E9467254EQ33865026-E1A43285-C9FD-42E4-850B-CE4CAA512793Q33865047-D0301297-1DB4-42D1-AADB-4B13DF909AF3Q34051953-E8274699-6D22-4A06-9BA5-093436EF2207Q34156811-ED1CAAFB-70B6-458C-9C41-1C91797B02D4Q34207776-9C4670F6-4CD2-4DC8-9CF1-28F57C1A72D4Q34563336-7A03805A-10DB-4BF2-8382-6B4B71F89B9AQ34572647-8785B99B-D7D4-44CA-BB32-19357FE9EC2EQ34645408-89F36473-F027-492D-80E9-F9E38D6D4A1DQ34663557-B86FD8F8-D1E1-46B8-B0C5-2B4386E6A2CBQ35009259-13A553D2-5344-4474-AB72-E8A7A2E9E1B0Q35175047-432F8B76-962A-4263-8ED0-7F179A501317Q35379752-ED1CDB3E-10C3-4FA5-96AE-DEACD0AE9E0FQ35397108-3B287882-CF06-475E-B934-FB2FB8DDF1C9Q35613910-C8013F8C-5848-44D1-A1CE-0100A2EA6D0FQ35751527-A936A862-64B6-42AF-A3C2-B452466051D0Q35753615-B1BE56DA-8F48-4382-9E18-7690FD140B4BQ35759867-0D634ACB-758F-4795-8831-D46C7278EEA0Q35763359-04CBD842-31D6-4F69-9557-B10B892872CAQ35767565-F3969F11-FBE0-4FDC-B486-BA5F8A4A6B15Q35776233-31AF9BBB-9265-440F-9580-E2856741FC4BQ35962604-5B30E5DC-0A2F-42E3-A07C-680926AA2688Q36063326-5E5310B6-68B0-444F-9175-7AE2F956BADFQ36063348-FDAC57EE-CE4B-4156-8AB2-487991BBA9DBQ36143931-30720689-A45C-4D06-9E99-8EDDAD37C4C3Q36215551-C0545AD8-50CE-4D38-B0C0-63487999442BQ36324566-06FF7F80-E480-4605-B746-A5A64BCFA0E5Q36370711-4E720635-6A9E-417E-B9CB-426B73302E45Q36409945-F6679890-4B00-4DC3-9811-02DF37C88CF9
P2860
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Five-year survival after resec ...... fluorodeoxyglucose (FDG-PET).
@en
Five-year survival after resec ...... y with F-18 fluorodeoxyglucose
@nl
type
label
Five-year survival after resec ...... fluorodeoxyglucose (FDG-PET).
@en
Five-year survival after resec ...... y with F-18 fluorodeoxyglucose
@nl
prefLabel
Five-year survival after resec ...... fluorodeoxyglucose (FDG-PET).
@en
Five-year survival after resec ...... y with F-18 fluorodeoxyglucose
@nl
P2093
P2860
P1433
P1476
Five-year survival after resec ...... fluorodeoxyglucose (FDG-PET).
@en
P2093
Barry A Siegel
David C Linehan
Farrokh Dehdashti
Felix G Fernandez
Jeffrey A Drebin
Steven M Strasberg
P2860
P304
438-47; discussion 447-50
P356
10.1097/01.SLA.0000138076.72547.B1
P407
P577
2004-09-01T00:00:00Z